Focus Stocks
Onyx Pharmaceuticals to Host a Teleconference to Reprise Key Data From the American Society of Hematology Meeting
Published on Tuesday, 06 December 2011 16:13 Written by TradersHuddle Staff
SOUTH SAN FRANCISCO, Calif., Dec. 6, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a teleconference and webcast to reprise key carfilzomib data presentations that were featured at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, California.
The teleconference will begin at 10:00 a.m. PT on December 13, 2011.
Interested parties may access the teleconference and the presentation that accompanies it on our website at:
http://www.onyx-pharm.com/investors/event-calendar
or by dialing 847-585-4405 and using the passcode 31296220. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 31296220# later in the day. The replay will be available on the Onyx website until December 27, 2011.
About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx-pharm.com.
SOURCE Onyx Pharmaceuticals, Inc.
Related Articles
- Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting
- Onyx Pharmaceuticals Reports First Quarter 2012 Financial Results
- Onyx Pharmaceuticals To Present At Upcoming Investor Conferences
- Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
- Onyx Pharmaceuticals to Report First Quarter 2012 Financial Results After Market on May 2, 2012
- Phase 3 Trial of Investigational Compound Regorafenib (BAY 73-4506) in Metastatic Gastrointestinal Stromal Tumors (GIST) Meets Primary Endpoint of Improving Progression-Free Survival
- Onyx Pharmaceuticals Announces Cell Publication Demonstrating Selectivity of Immunoproteasome Inhibitor ONX 0914
- Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma
- Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2011 Financial Results
- Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
Related Partner Headlines
- Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma - Benzinga
- Onyx Stock Hits New 52-Week High (ONXX) - TheStreet.com
- Notable Options Activity in Onyx Pharmaceuticals, Inc - Benzinga
- Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma - Benzinga
- Notable Call Options Activity in Onyx Pharmaceuticals - Benzinga
- Morgan Stanley Initiates Coverage on Onyx Pharmaceuticals at Underweight, Announces PT of $38 - Benzinga
- Onyx Pharmaceuticals to Consider Sale: Reports - TheStreet.com
- Onyx Rises On Unusually High Volume (ONXX) - TheStreet.com
- Onyx Stock Gaps Up On Today's Open (ONXX) - TheStreet.com
- Onyx Rises On Unusually High Volume (ONXX) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Attention Gold Bulls: Oil Is Leading the Way - TheStreet.com -
Knightsbridge Tankers Stock Hits New 52-Week Low (VLCCF) - TheStreet.com -
Brown Shoe Stock Hits New 52-Week High (BWS) - TheStreet.com -
Cooper Industries: S&P Intraday Gainer - TheStreet.com -
Exelon Stock Hits New 52-Week Low (EXC) - TheStreet.com -
Wynn Stock Hits New 52-Week Low (WYNN) - TheStreet.com -
A Primer on Post-2008 Risk Management - TheStreet.com -
Acme Packet Stock Hits New 52-Week Low (APKT) - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,463.98 Trade time:11:09AM EDT Value change:▲94.60 (0.76%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,308.97 Trade time:11:09AM EDT Value change:▲13.75 (1.06%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,813.66 Trade time:11:09AM EDT Value change:▲34.87 (1.25%)In The Wires
-
SYNNEX Corporation Moves Up on Fortune 500 List for 6th Year in a Row -
Thunderbird Hosts Global Business Dialogue in Berlin -
CORRECTING and REPLACING Douglas and Sandra Bergeron Fund Endowment at Georgetown University Medical Center -
Boardwalk to Present at 2012 Master Limited Partnership Investor Conference -
ADDING and REPLACING Green Dot Announces New Exclusive Distribution and Key Contract Renewals -
QED Proof of Concept Program Opens Fifth Round With New Participants and New Special Emphasis Topic -
Pie Five Pizza Co. Brings Zen to the Menu With Sweet Thai Pie -
SGOCO Announces Delay of 2011 Year End Financial Results Due to Change of Auditor









